John Barbieri, MD, MBA, is an associate professor at Harvard Medical School and director of the Advanced Acne Therapeutics Clinic at Brigham and Women’s Hospital.
Barbieri is also an associate director at JAMA Dermatology and cochair of the American Academy of Dermatology Acne Guidelines Work Group.
Barbieri’s research is focused on conducting innovative clinical trials and health economic and epidemiology studies to identify the best approaches to care for patients with chronic skin diseases such as acne, rosacea, psoriasis and atopic dermatitis.
Barbieri also focuses on exploring the role of

Tina Bhutani, MD, MAS, is associate clinical professor of dermatology at the University of California, San Francisco, and CEO of Synergy Dermatology.
Bhutani specializes in the treatment of inflammatory skin conditions, including psoriasis and atopic dermatitis.
“My research focuses on the comprehensive care of skin disease. We should not just be treating the skin, but rather the person living with the skin disease,” Bhutani told Healio.
See Bhutani’s Healio Dermatology Peer Perspective Board member contributions here.

Dawn Marie R. Davis, MD, is professor of dermatology and pediatrics at Mayo Clinic in Rochester, Minnesota. Davis is also founder and leader of the section of pediatric dermatology and the pediatric dermatology fellowship.
“The impact of skin disease on the quality of life of patients and their families is immense. I am passionate about advancing the science of medicine to ensure patients can thrive,” Davis told Healio.
See Davis’ Healio Dermatology Peer Perspective Board member contributions here.

Lawrence F. Eichenfield, MD, is professor of dermatology and pediatrics and vice chair of the department of dermatology at the University of California, San Diego.
Eichenfield is also chief of pediatric and adolescent dermatology at Rady Children’s Hospital-San Diego and directs the UCSD/Rady Children’s Eczema and Inflammatory Skin Disease and Rare Skin Disease centers.
“I am a pediatric dermatologist dedicated to advancing the fields of pediatric dermatology, inflammatory skin diseases and rare skin disorders through research, education and advancing best practices in clinical care,”

Anthony P. Fernandez, MD, PhD, is clinical assistant professor of medicine at Cleveland Clinic Lerner College of Medicine and director of medical dermatology and the W.D. Steck Chair of Clinical Dermatology at Cleveland Clinic.
Fernandez is a dermatologist and dermatopathologist whose practice and research focuses on complex medical dermatology.
“Both my clinical and research interests focus on complex medical dermatology, especially dermatology-rheumatology overlap diseases. My research ranges from translational studies to serving as a principal investigator in various clinical trials,”

Adam Friedman, MD, FAAD, is professor and chair of the department of dermatology at George Washington University School of Medicine and Health Sciences.
Friedman is also residency program director, director of translational research and director of supportive oncodermatology.
“My work centers on advancing dermatology education and translating clinical research into practice, with a focus on emerging therapeutics, inflammatory skin disease and evidence-based strategies that improve patient outcomes. I also explore nanotechnology-driven drug delivery innovations and lead community-based

Emma Guttman-Yassky, MD, PhD, is the Waldman Professor of Dermatology and Immunology and the health system chair of the department of dermatology at Icahn School of Medicine at Mount Sinai.
Guttman-Yassky is also director of the Center for Excellence in Eczema and the Laboratory for Inflammatory Skin Diseases and co-director of the Mount Sinai Clinique Skin Aging Center.
Guttman-Yassky’s research interests include atopic dermatitis/eczema, hair loss disorders and skin aging.
See Guttman-Yassky’s Healio Dermatology Peer Perspective Board member contributions here.

John E. Harris, MD, PhD, is the inaugural chair of dermatology at Mass General Brigham Hospital.
Harris is a dermatologist and physician-scientist. He runs a vitiligo specialty clinic and a research laboratory.
“My career goal is to reveal mechanisms of autoimmunity in the skin, develop new treatments using animal models and translate these treatments to patients. We use basic, translational and clinical research approaches as a seamless integrated strategy to better understand autoimmune pathogenesis, in particular the mechanisms that drive autoimmunity in vitiligo,” Harris told Healio.
See

Jennifer L. Hsiao, MD, is associate professor of dermatology at Keck School of Medicine at University of Southern California.
Hsiao also serves as director of the Hidradenitis Suppurativa Specialty Clinic.
“I am dedicated to increasing awareness and education, advancing research and improving the lives of patients living with hidradenitis suppurativa,” Hsiao told Healio.
See Hsiao’s Healio Dermatology Peer Perspective Board member contributions here.

Brett King, MD, PhD, is a dermatologist in private practice at Dermatology Physicians of Connecticut and former associate professor of dermatology at Yale University School of Medicine.
King pioneered the use of JAK inhibitors in dermatology, and his work revealed the broad utility of JAK inhibitors for the treatment of alopecia areata, vitiligo, atopic dermatitis, granulomatous diseases and other conditions.
See King’s Healio Dermatology Peer Perspective Board member contributions here.